cd8+t cell cross-priming via transfer proteasome substrates
cross-priming describes activation naive cd8+ t cells professional antigen-presenting cells acquired viral tumor antigens donor cells antigen transfer believed mediated donor cell-derived molecular chaperones bearing short peptide ligands generated proteasome degradation protein antigens show cross-priming based transfer proteasome substrates rather peptides findings potentially important rational design vaccines elicit cd8+ t cell responses
